top of page

Olivier Gouédard, PharmD, MBA

Chief Operating Officer

Prior to joining Cytovia, Dr. Gouédard was Vice President, Global Cell Therapy Franchise at Bristol Myers Squibb, where he led the cross-functional development of CAR T cell therapies for multiple myeloma. Prior to Bristol Myers Squibb, he spent 8 years at Celgene as Executive Director, Global Project Leadership, leading global development teams for multiple early and late-stage assets in Hematology/Oncology and Inflammation/Immunology. Prior to his role at Celgene, Dr. Gouédard worked at Amgen where he advanced through positions in Finance, Project Management, Sales and Marketing.

 

Dr. Gouédard holds a Doctorate in Pharmacy from the University of Rennes I, France, an advanced degree in Experimental and Clinical Pharmacology from the Paris-Sud University, Paris, France, and an MBA in Finance/Accounting from the Stern School of Business, New York University.

bottom of page